Use Your Voice: Pharmacists as Patient Advocates
Drug Topics
AUGUST 6, 2024
From expanding vaccination coverage to battling with PBMs, the community pharmacist has the ability to promote change like never before.
Sat.Aug 03, 2024 - Fri.Aug 09, 2024
205 
FDA Approves First Nasal Spray for Anaphylaxis
Pharmacy Times
AUGUST 9, 2024
neffy is an epinephrine nasal spray for the emergency treatment of allergic reactions in adults and pediatric patients.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opinion: Noah Lyles’ collapse with Covid: How not to manage health at the Olympics
STAT
AUGUST 9, 2024
Noah Lyles, a 27-year-old from Gainesville, Florida, has had himself quite an Olympics. He won a gold medal in a photo finish in the 100-meter dash on August 4. He went on to win a bronze medal in the 200-meter dash four days later, then collapsed in a heap and needed a wheelchair to get off the track, suggesting that sports officials and team doctors have put athletes’ health last, not first, during the Paris Olympics.
Novartis and Viatris sued by estate of Henrietta Lacks, whose cells were extracted for research in 1951
Fierce Pharma
AUGUST 5, 2024
The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from | The family of a Baltimore woman whose cells were extracted for medical research without her consent more than 70 years ago has filed another lawsuit against drugmakers that allegedly profited from the discoveries they made using her genetic material.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Student, Staffing Shortages Continue to Impact Pharmacy Profession
Drug Topics
AUGUST 6, 2024
The COVID-19 pandemic led to increased pharmacist burnout and workforce shortages. The impact is still being felt today.
Human Pluripotent Stem Cell Line Variability Supports Successful Cortical Organoid Production
Pharmacy Times
AUGUST 5, 2024
Small adjustments in human pluripotent stem cell cultures and the molecule concentration patterns in the initial 5 days of differentiation are essential to “rescue” the lines.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
BioNTech posts €808M loss as company continues to come to grips with seasonal COVID vaccine market
Fierce Pharma
AUGUST 5, 2024
While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market. | While Pfizer’s German mRNA partner BioNTech has high hopes for its post-COVID future, the company continues to feel the squeeze from the changeover to a seasonal vaccine market.
Healthful Diets Are Crucial, But Population-Level Follow-Through Remains a Challenge
Drug Topics
AUGUST 3, 2024
Health care professionals all agree that a healthy diet is the foundation of cardiovascular and cardiometabolic health, but follow-through on the population level is lacking.
Report: Satisfaction of Mail-Order Pharmacies Rise, Decreases for Community Pharmacies
Pharmacy Times
AUGUST 5, 2024
Customers report that their communication is strong with their pharmacists, but only 51% said their pharmacist was trustworthy.
FDA approves EpiPen alternative, a nasal spray for anaphylaxis
STAT
AUGUST 9, 2024
On Friday, the Food and Drug Administration approved the first needle-free treatment for adults and kids with severe allergic reactions. The approval introduces a competitor from ARS Pharma to older epinephrine products, like the EpiPen. Neffy, as the product is called, is a nasal spray that delivers the same drug used to treat anaphylaxis. It is ARS’ flagship product.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Epic rolls out new feature to make it easier for patients to share medical records with health apps
Fierce Healthcare
AUGUST 4, 2024
Medical records software giant Epic has rolled out a new feature that makes it easier for patients to release their medical records to the health or wellness apps they use. | The new capability is part of a wider effort by the healthcare industry, facilitated by new health tech policies from the federal government, to advance data-sharing at scale.
Cannabis Use Associated with Increased Risk of Head and Neck Cancer
Drug Topics
AUGUST 9, 2024
A cohort study was conducted to address the association between patients with cannabis-related disorders and their risk of developing head and neck cancer.
Expert: Psychosis in Alzheimer Disease Contributes to Rapid Cognitive, Functional Decline
Pharmacy Times
AUGUST 3, 2024
In addition to a rapid deterioration, psychosis in Alzheimer disease can also lead to poorer quality of life, damaging patients’ relationships with caregivers, and increases isolation.
FDA rejects MDMA as a psychedelic treatment for PTSD
STAT
AUGUST 9, 2024
The Food and Drug Administration rejected MDMA as a treatment for post-traumatic stress disorder on Friday, in a blow to drug activists and veterans who’ve long campaigned for the psychedelic treatment. Although two Phase 3 trials suggested the treatment was effective, strong opposition by an agency scientific advisory committee in June and allegations of missing adverse event data and research bias may have doomed the application by Lykos Therapeutics.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Appeals court upholds ruling that struck down surprise billing arbitration process
Fierce Healthcare
AUGUST 6, 2024
A federal appeals court has upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing. | A federal appeals court upheld a lower court decision that struck down key parts of legislation aimed at reforming surprise medical billing.
The 2024-2025 Flu Season: What to Expect
Drug Topics
AUGUST 9, 2024
The composition of the latest flu vaccine has changed. Here’s what pharmacists need to know.
New Evidence Supports Cholesterol Absorption Inhibitors in Liver Cancer Prevention
Pharmacy Times
AUGUST 9, 2024
Statins and non-statin cholesterol-lowering agents show potential in reducing the risk of liver cancer.
Scientists are starting to uncover how neighborhood can affect the biology of cancer
STAT
AUGUST 8, 2024
Where you live has a relationship to your odds of getting cancer and surviving cancer. Epidemiologists studying this link they see in the data have focused on so-called social determinants of health — poor access to transportation, for example, could make it harder for residents to see a doctor. Places lacking grocery stores with fresh food could mean worse nutrition for locals.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos
Fierce Pharma
AUGUST 8, 2024
Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. government. | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8 million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox.
Problematic Opioid Prescribing Among Patients with Chronic Pain
Drug Topics
AUGUST 8, 2024
Researchers conducted a systematic review of literature exploring the misuse of opioid prescriptions for patients with chronic non-cancer pain.
GLP-1 Agonists Show Promise in Treatment of Neurodegenerative Disorders
Pharmacy Times
AUGUST 7, 2024
Significant commonalities between type 2 diabetes and neurodegenerative disorders suggest that treatments effective for one condition may benefit the other.
As Covid deaths drop, heart disease and cancer remain leading causes of death
STAT
AUGUST 8, 2024
Since its emergence in 2020, Covid has jumbled the list of the 10 leading causes of deaths in the United States. It roared into third place in 2020 but has now fallen to 10th place, the National Center for Health Statistics reported Thursday. Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. 3.
ASTP/ONC proposal would require HHS contractors to use certified health IT tech
Fierce Healthcare
AUGUST 8, 2024
The Department of Health and Human Services’ technology office dropped a new proposed rule on Thursday that would require healthcare entities that contract with HHS to use government-cert | The newly rebranded Office of the Assistant Secretary of Technology Policy released a proposed rule Thursday that could expand the use of government-certified health technology.
Weekend ICYMI: July 29 to August 2
Drug Topics
AUGUST 4, 2024
In case you missed it, this week we had news about CVS in the spotlight of PBM reform, landmark FDA approvals in synovial sarcoma, liraglutide for dementia, and more.
Study Finds Abacavir Increases Cardiovascular Risk in Patients With HIV
Pharmacy Times
AUGUST 7, 2024
Cholesterol-lowering agents, like statins, reduced the risk of major adverse cardiovascular events and cardiovascular disease in patients with HIV.
STAT+: How UnitedHealth turned a questionable artery-screening program into a gold mine
STAT
AUGUST 7, 2024
The nation’s largest health care company pressed thousands of its clinicians to use a thinly tested medical device to screen people for artery disease, dramatically boosting payments from the federal government for years even though many of the patients were not sick, a STAT investigation found. The result was a torrent of sometimes questionable diagnoses of peripheral artery disease.
FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer
Fierce Healthcare
AUGUST 6, 2024
FDA releases roster of digital health advisory committee, chaired by American College of Cardiology innovation officer ebeavins Tue, 08/06/2024 - 10:26
Online Pharmacies Are Illegally Selling GLP-1s Without Prescriptions
Drug Topics
AUGUST 5, 2024
A study found that test products purchased from illegal online pharmacy operations had lower purity levels and significantly more semaglutide content than what was advertised on the label.
Developing Relationships With State Boards of Pharmacy Is Valuable for Pharmacies and Pharmacists
Pharmacy Times
AUGUST 5, 2024
A pharmacy's relationship with its state board(s) of pharmacy is crucial for its operation and success, yet it is often overlooked due to the complex demands on pharmacists and pharmacy owners.
Opinion: Diversity statements should not be required for federal STEMM grant funding
STAT
AUGUST 5, 2024
Federally funded research in science, technology, engineering, mathematics, and medicine (STEMM) is a crown jewel of American higher education that confers enormous benefits upon the U.S. and the world. The integrity of the processes by which funding decisions are made is critically important to the success of the enterprise and its support by the public who pay for this research.
Big Health clinches FDA clearance of its digital therapeutic for insomnia, SleepioRx
Fierce Healthcare
AUGUST 8, 2024
Big Health, a maker of digital treatments for mental health, has clinched Food & Drug Administration (FDA) clearance of its product for insomnia, Fierce Healthcare has learned in an a | SleepioRx, its flagship digital therapeutic, is intended for the treatment of chronic insomnia and insomnia disorder as an adjunct to usual care in adults over 18.
As FDA Decision on MDMA for PTSD Looms, What Would Approval Mean for Mental Health Treatment?
Drug Topics
AUGUST 8, 2024
Sam Clark, MD, PhD, founder and CEO of Terran Biosciences, discusses the implications of a potential FDA approval of MDMA-assisted therapy for PTSD.
Study Finds Safe, Effective Way of Infecting Participants With the Parasite Causing Leishmaniasis
Pharmacy Times
AUGUST 7, 2024
This breakthrough can be significant in the development for a vaccine and other preventative measures to protect individuals from leishmaniasis.
Let's personalize your content